New antibody TRL345 tested in healthy volunteers for first time
Knowledge-focused
Completed
This early-stage study tested a single dose of TRL345, an antibody designed to fight cytomegalovirus (CMV), in 16 healthy adults. The main goal was to check safety and how the body processes the drug. Results will help plan future studies in transplant patients who are at high ri…
Phase: PHASE1 • Sponsor: Trellis Bioscience LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC